Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Jan 10, 2014 (13 years ago)

Dermamedics Complexion Repair Topical Rehydrating Emulsion in 50…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.

Cause type: Unapproved drug

The product was marketed without an approved NDA/ANDA, or does not meet the OTC monograph it claims to follow. Nothing about the product - dose, purity, safety - has been reviewed by FDA, so the claims on the box are unverified. All unapproved drug recalls.

What was recalled

Dermamedics Complexion Repair Topical Rehydrating Emulsion in 50 ml and 30 ml containers in the Dermamedics Complexion Repair Acne Treatment System Kit with SKU numbers of DM 1013 and DM 1025, respectively; Therametics Complexion Repair Topical Rehydrating Emulsion which was distributed in 50 ml containers with a SKU number of CR002 and in 50 ml containers in the Therametics Complexion Repair Acne Treatment System Kit with a SKU number of CR1005; and in 30 ml containers in the Therametics Complexion Repair Acne Travel Kit with a SKU number of CR1007.

Recalling firm
Dermamedics, L.L.C.
Origin
OK, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1494-2014 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other recalls by Dermamedics, L.L.C.

All 2014 recalls
Class II · Moderate risk

Dermamedics Calm and Correct Serum

Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.

Terminated Unapproved drug Dermamedics, L.L.C. D-1491-2014

Other unapproved drug recalls from 2014

All unapproved drug recalls
Class II · Moderate risk

B-Lipo

Marketed without an Approved NDA/ANDA; found to contain Lorcaserin, a controlled substance used for weight loss

Terminated Unapproved drug Bethel Nutritional Consulting, Inc D-0424-2015
Class I · High risk

Professional Formexx Black

Marketed without an approved NDA/ANDA - These products are being recalled due to the presence of synthetic hormone/prohormone (methylated anabolic steroid) ingredient making them unapproved new drugs.

Terminated Unapproved drug Anabolic Science Labs, LLC D-0990-2015
Class I · High risk

Swoll-250 Super Mass Builder Quad Stack

Marketed without an approved NDA/ANDA - These products are being recalled due to the presence of synthetic hormone/prohormone (methylated anabolic steroid) ingredient making them unapproved new drugs.

Terminated Unapproved drug Anabolic Science Labs, LLC D-0989-2015
Class I · High risk

Estrastain Pro-Anabolic Mass and Hardening Complex

Marketed without an approved NDA/ANDA - These products are being recalled due to the presence of synthetic hormone/prohormone (methylated anabolic steroid) ingredient making them unapproved new drugs.

Terminated Unapproved drug Anabolic Science Labs, LLC D-0988-2015